Clinical Trial Detail

NCT ID NCT03531840
Title Olaparib in People With Malignant Mesothelioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

malignant mesothelioma

Therapies

Olaparib

Age Groups: adult senior

No variant requirements are available.